Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul C Potter

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|February 5, 2005
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year studyKim A Papp, Thomas Werfel, Regina Fölster-Holst, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 25, 2005
Low prevalence of latex sensitivity in South African spina bifida children in Cape TownAsmah Johar, Dawn L Lim, Siti Arija Mad Arif, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2002
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drugAlexander Kapp, Kim Papp, Ann Bingham, et al.
Molecular Immunology|December 24, 2014
A complement C5 gene mutation, c.754G>A:p.A252T, is common in the Western Cape, South Africa and found to be homozygous in seven percent of Black African meningococcal disease casesE Patricia Owen, Reinhard Würzner, Felicity Leisegang, et al.
The World Allergy Organization Journal|January 4, 2013
Requirements for physician competencies in allergy: key clinical competencies appropriate for the care of patients with allergic or immunologic diseases: a position statement of the world allergy organizationMichael A Kaliner, Sergio Del Giacco, Carlos D Crisci, et al.
International Archives of Allergy and Immunology|January 3, 2006
Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training CouncilJohn O Warner, Michael A Kaliner, Carlos D Crisci, et al.
The World Allergy Organization Journal|January 4, 2013
What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007Sergio Del Giacco, Lanny J Rosenwasser, Carlos D Crisci, et al.
The World Allergy Organization Journal|December 27, 2012
Sub-lingual immunotherapy: world allergy organization position paper 2009G Walter Canonica, Jean Bousquet, Thomas Casale, et al.
Allergy|January 1, 2010
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009G Walter Canonica, Jean Bousquet, Thomas Casale, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|February 5, 2005
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year studyKim A Papp, Thomas Werfel, Regina Fölster-Holst, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 25, 2005
Low prevalence of latex sensitivity in South African spina bifida children in Cape TownAsmah Johar, Dawn L Lim, Siti Arija Mad Arif, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2002
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drugAlexander Kapp, Kim Papp, Ann Bingham, et al.
Molecular Immunology|December 24, 2014
A complement C5 gene mutation, c.754G>A:p.A252T, is common in the Western Cape, South Africa and found to be homozygous in seven percent of Black African meningococcal disease casesE Patricia Owen, Reinhard Würzner, Felicity Leisegang, et al.
The World Allergy Organization Journal|January 4, 2013
Requirements for physician competencies in allergy: key clinical competencies appropriate for the care of patients with allergic or immunologic diseases: a position statement of the world allergy organizationMichael A Kaliner, Sergio Del Giacco, Carlos D Crisci, et al.
International Archives of Allergy and Immunology|January 3, 2006
Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training CouncilJohn O Warner, Michael A Kaliner, Carlos D Crisci, et al.
The World Allergy Organization Journal|January 4, 2013
What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007Sergio Del Giacco, Lanny J Rosenwasser, Carlos D Crisci, et al.
The World Allergy Organization Journal|December 27, 2012
Sub-lingual immunotherapy: world allergy organization position paper 2009G Walter Canonica, Jean Bousquet, Thomas Casale, et al.
Allergy|January 1, 2010
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009G Walter Canonica, Jean Bousquet, Thomas Casale, et al.
Pageof 4